Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CALC

CalciMedica Inc

Last Close
Dec 08 • 04:00PM ET
3.89
Dollar change
+0.51
Percentage change
14.92 		%
Scroll to Statements
Index- P/E- EPS (ttm)-23.20 Insider Own65.89% Shs Outstand5.68M Perf Week-1.02%
Market Cap22.10M Forward P/E- EPS next Y-3.50 Insider Trans2.10% Shs Float1.94M Perf Month7.76%
Income-35.60M PEG- EPS next Q-1.01 Inst Own5.18% Short Float / Ratio0.60% / 0.62 Perf Quarter25.08%
Sales0.00M P/S- EPS this Y-42.22% Inst Trans2.85% Short Interest0.01M Perf Half Y-25.90%
Book/sh23.21 P/B0.17 EPS next Y51.56% ROA-65.48% Target Price10.12 Perf Year-53.77%
Cash/sh6.89 P/C0.56 EPS next 5Y- ROE-70.51% 52W Range1.00 - 10.62 Perf YTD-44.43%
Dividend- P/FCF- EPS past 5Y-0.51% ROI-98.98% 52W High-63.39% Beta1.78
Dividend %- Quick Ratio10.72 Sales past 5Y0.00% Gross Margin- 52W Low289.00% ATR0.44
Employees8 Current Ratio10.72 Sales Q/Q- Oper. Margin0.00% RSI (14)59.99 Volatility11.28% 12.78%
OptionableNo Debt/Eq0.01 EPS Q/Q15.88% Profit Margin- Rel Volume0.33 Prev Close3.38
ShortableYes LT Debt/Eq0.00 EarningsNov 09 BMO Payout- Avg Volume18.72K Price3.89
Recom1.00 SMA2011.64% SMA5038.31% SMA200-1.63% Volume6,117 Change14.92%
Nov-09-23 07:00AM
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(PR Newswire) -12.74%
Nov-02-23 09:15AM
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
(PR Newswire) +10.23%
Sep-06-23 07:30AM
CalciMedica Announces Upcoming Presentations and Events in September
(PR Newswire) +5.18%
Aug-31-23 07:30AM
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
(PR Newswire)
Aug-11-23 07:01AM
Daily Vickers Top Insider Picks for 08/11/2023
(Argus Research)
04:05PM Loading…
Aug-10-23 04:05PM
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(GlobeNewswire)
06:24AM
Daily Vickers Top Insider Picks for 08/10/2023
(Argus Research)
Aug-09-23 07:30AM
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP)
(GlobeNewswire) +6.06%
06:26AM
Daily Vickers Top Insider Picks for 08/09/2023
(Argus Research)
Aug-08-23 06:28AM
Daily Vickers Top Insider Picks for 08/08/2023
(Argus Research)
Aug-07-23 06:35AM
Daily Vickers Top Insider Picks for 08/07/2023
(Argus Research)
Aug-04-23 07:14AM
Daily Vickers Top Insider Picks for 08/04/2023
(Argus Research)
Aug-03-23 07:15AM
Daily Vickers Top Insider Picks for 08/03/2023
(Argus Research)
Aug-02-23 07:52AM
Daily Vickers Top Insider Picks for 08/02/2023
(Argus Research)
Aug-01-23 06:51AM
Daily Vickers Top Insider Picks for 08/01/2023
(Argus Research) -6.29%
06:44AM Loading…
Jul-31-23 06:44AM
Daily Vickers Top Insider Picks for 07/31/2023
(Argus Research)
Jul-28-23 07:58AM
Daily Vickers Top Insider Picks for 07/28/2023
(Argus Research)
Jul-27-23 07:10AM
Daily Vickers Top Insider Picks for 07/27/2023
(Argus Research)
Jul-26-23 01:12PM
Daily Vickers Top Insider Picks for 07/26/2023
(Argus Research)
Jul-25-23 07:16AM
Daily Vickers Top Insider Picks for 07/25/2023
(Argus Research) -6.11%
Jul-24-23 07:12AM
Daily Vickers Top Insider Picks for 07/24/2023
(Argus Research)
Jul-21-23 07:23AM
Daily Vickers Top Insider Picks for 07/21/2023
(Argus Research)
Jul-20-23 06:55AM
Daily Vickers Top Insider Picks for 07/20/2023
(Argus Research)
Jul-19-23 07:10AM
Daily Vickers Top Insider Picks for 07/19/2023
(Argus Research)
Jul-18-23 06:53AM
Daily Vickers Top Insider Picks for 07/18/2023
(Argus Research) -5.56%
Jul-17-23 07:10AM
Daily Vickers Top Insider Picks for 07/17/2023
(Argus Research) +5.16%
Jul-14-23 06:50AM
Daily Vickers Top Insider Picks for 07/14/2023
(Argus Research)
Jul-13-23 07:02AM
Daily Vickers Top Insider Picks for 07/13/2023
(Argus Research)
Jul-12-23 07:22AM
Daily Vickers Top Insider Picks for 07/12/2023
(Argus Research) +7.08%
Jul-11-23 06:08AM
Daily Vickers Top Insider Picks for 07/11/2023
(Argus Research)
06:56AM Loading…
Jul-10-23 06:56AM
Daily Vickers Top Insider Picks for 07/10/2023
(Argus Research)
Jul-05-23 06:46AM
Daily Vickers Top Insider Picks for 07/05/2023
(Argus Research) +13.07%
Jul-03-23 06:50AM
Daily Vickers Top Insider Picks for 07/03/2023
(Argus Research)
Jun-30-23 06:52AM
Daily Vickers Top Insider Picks for 06/30/2023
(Argus Research) -17.32%
Jun-29-23 06:49AM
Daily Vickers Top Insider Picks for 06/29/2023
(Argus Research) +11.75%
Jun-28-23 06:58AM
Daily Vickers Top Insider Picks for 06/28/2023
(Argus Research)
Jun-27-23 06:46AM
Daily Vickers Top Insider Picks for 06/27/2023
(Argus Research) +28.00%
Jun-26-23 06:41AM
Daily Vickers Top Insider Picks for 06/26/2023
(Argus Research)
Jun-23-23 09:24AM
Daily Vickers Top Insider Picks for 06/23/2023
(Argus Research) -6.76%
Jun-12-23 07:30AM
CalciMedica Announces Relisting on Nasdaq
(GlobeNewswire)
Jun-06-23 07:30AM
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
(GlobeNewswire) +16.85%
May-23-23 07:30AM
CalciMedica Expands Executive Team with New Appointments
(GlobeNewswire) +9.49%
May-15-23 08:55AM
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
(GlobeNewswire)
Mar-29-23 07:53PM
Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential
(TipRanks) -8.76%
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leheny A. RachelChief Executive OfficerNov 07Buy3.342,0006,68018,840Nov 08 08:42 PM
Leheny A. RachelChief Executive OfficerNov 06Buy3.122,4407,61516,840Nov 07 06:09 PM
Roberts Eric WChief Business OfficerNov 06Buy3.122,4007,48835,894Nov 08 08:41 PM
Hebbar SudarshanChief Medical OfficerNov 03Buy2.7436,00098,60046,000Nov 07 06:08 PM
Roberts Eric WChief Business OfficerNov 03Buy2.8311,24931,84633,494Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03Buy2.705,86015,82822,245Nov 06 06:40 PM
Leheny A. RachelChief Executive OfficerNov 03Buy2.855,00014,25014,400Nov 06 06:39 PM
Roberts Eric WChief Business OfficerNov 03Buy2.773,70010,24920,287Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03Buy2.803,2008,96016,587Nov 06 06:40 PM
Roberts Eric WChief Business OfficerAug 25Buy3.187362,3405,000Aug 29 07:34 PM
Roberts Eric WChief Business OfficerAug 22Buy3.277142,3354,264Aug 23 06:02 PM
Roberts Eric WChief Business OfficerAug 21Buy3.251,7505,6883,550Aug 23 06:02 PM
Roberts Eric WChief Business OfficerJun 26Buy3.701,2004,44113,387Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 26Buy3.5320070616,385Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 23Buy3.355001,67516,185Jun 26 08:33 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.